RIEFLIN WILLIAM JL enters LYCIA THERAPEUTICS, INC. with 89.78K shares plus derivative instruments
Holding both equity and derivatives at entry signals strong long-term conviction in the company.
Indirect Derivatives
Filed: 10/22/2026ACC: 0001182471-26-000005
Director
Since Oct 2026
89.78K
Baseline shares
0.00
Direct ownership
0 positions
59.22K
Derivative underlying
2 instruments
1
Security positions
89.78K indirect
Non-Derivative Holdings1
Common Stock
IndirectShares owned89.78K
Total
89.78K indirect89.78K
| Security Title | Shares Owned | Ownership Type |
|---|---|---|
| Common Stock | 89.78K | Indirect |
| Total | 89.78K | 89.78K indirect |
Derivative Holdings2
Stock Option (Right to Buy)
DirectUnderlying security
Common Stock
Underlying shares
34.38K
Shares owned
N/A
Exercise price
2.44
Expiration
—
Exercise window
—
Stock Option (Right to Buy)
DirectUnderlying security
Common Stock
Underlying shares
24.84K
Shares owned
N/A
Exercise price
3.70
Expiration
—
Exercise window
—
Total
Underlying
59.22K
Owned
0.00
| Security | Underlying | Exercise Price | Exercise Window | Expiration | Underlying Shares | Shares Owned |
|---|---|---|---|---|---|---|
| Stock Option (Right to Buy) Direct | Common Stock | 2.44 | — | — | 34.38K | N/A |
| Stock Option (Right to Buy) Direct | Common Stock | 3.70 | — | — | 24.84K | N/A |
| Total | 59.22K | 0.00 | ||||